BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35276691)

  • 21. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE; Stenbäck F; Tapanainen JS
    Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model.
    Rojewska E; Ciapała K; Mika J
    Pharmacol Rep; 2019 Feb; 71(1):139-148. PubMed ID: 30550994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the IL-17 signalling pathway by the CXCL17-GPR35 axis affects drug resistance and colorectal cancer tumorigenesis.
    Bu J; Yan W; Huang Y; Lin K
    Am J Cancer Res; 2023; 13(5):2172-2187. PubMed ID: 37293165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
    Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
    Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
    Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
    Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression.
    Matsui A; Yokoo H; Negishi Y; Endo-Takahashi Y; Chun NA; Kadouchi I; Suzuki R; Maruyama K; Aramaki Y; Semba K; Kobayashi E; Takahashi M; Murakami T
    PLoS One; 2012; 7(8):e44080. PubMed ID: 22952881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17.
    Liu W; Xie X; Wu J
    Cell Oncol (Dordr); 2020 Apr; 43(2):311-320. PubMed ID: 31832986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and clinical significance of KISS-1 and GPR54 mRNA in endometrial carcinoma].
    Jiang T; Zhang SL; Lin B; Meng LR; Gao H
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):229-31. PubMed ID: 15949424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
    Liang S; Huang C; Jia S; Wang B
    Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
    Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
    Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High expression of MMP20 may be a potential prognostic factor for poor outcomes of patients with endometrial carcinoma].
    Zhao Q; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1239-1244. PubMed ID: 30377136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.